Coronary Stents - Global Market Trends

1.METHODOLOGY
Study Reliability and Reporting Limitations
Disclaimers
Quantitative Techniques & Reporting Level
2.GLOBAL MARKET OVERVIEW
Drug Eluting Stents Steal the Show
Cypher and Taxus Dominate Global DES Market
A 10-Year Outlook for the Coronary Stents Industry
3.MARKET TRENDS AND ISSUES
Drug Eluting Stent System – Safety Concerns
Drug Eluting Stent Market to Bounce Back
Coronary Stents Market Challenged by Drug Therapy
Restenosis - the Real Growth Driver
Small Vessels – A Major Cause of Restenosis
Aging Population Propels Coronary Stent Market…
Cell Transplantation – A Major Threat to Coronary Stents
Next Generation Stents – A Boon for Treating Coronary Diseases…
Direct Stenting Systems Spur Growth
Drug Choice Impacts Market Entry
Price and Quality Concerns Dog Supplies and Demand for DES…
DES’ Introduction Skyrockets Coronary Stent Prices…
Legal Challenges Right Behind
New Competition Puts Tabs on Coronary Stenting
4.COMPETITIVE ANALYSIS
5.PRODUCT FACTS
Bare Metal Stents
Major Bare Metal Stents by Company
Drug Eluting Stents
Major Drug-Eluting Stents by Company
A Peek into Regulatory Approvals for Coronary Stents
6.RESEARCH AND DEVELOPMENT
Extensive R&D Underway in Global Drug- Eluting Stents Market
At the Labs
Other Products Under Trials – A Recent Past Perspective
OMT Developing R-stent
Reva Developing Stainless Steel Bare- Metal Stent
D & P Corp Developing Bovine Pericardium - Covered Stent…
Advanced Bio Synthesizing Porous Drug - Eluting Stents…
Lombard Medical Developing PEP Coatings…
Shiga Develops Biodegradable Drug- Eluting Stent
7.CORPORATE DEVELOPMENTS
Medtronic Receives the US FDA Approval to Use Endeavor® Stent
Medtronic Inc. Receives Approval for its Drug- Eluting Stent, "Endeavor" In Canada
Boston Scientific to Market TAXUS® Liberte® Stent System in Canada
Abbott Applies for Approval of XIENCE™ V in Japan
Medinol Achieves CE Mark Approval for Presillion™ Cobalt Chromium Coronary Stent System
Iberhospitex Receives Spanish Approval to Sell Palau Pharma’s "Active" Coronary Stent
Clearstream’s Intrepide Drug Eluting Stent of Clearstream Receives CE mark approval
Terumo Introduces Its Drug-Eluting Stent inGermany and Marks Its European Entry
Tryton Medical’s Side-Branch Stent Achieves CE Mark Approval
CV Therapeutics Offers its Stent Coating Technology to Medlogics Device Corporation
Abbott’s 2.25mm-Sized XIENCE™ V Drug Eluting Stent receives CE Mark of Approval
Biosensors Receives CE Mark Approval For BioMatrix® Stent System
Nfocus Neuromedical’s CardioVasc™ Stent-Graft and Delivery System Receives CE Mark Approval
InspireMD - MGuard™ Coronary Stent Launched in Italy
CeloNova BioSciences Launches CATANIA™ Coronary Stent with Nano Thin Polyzene®-F
Angiotech Launches Cook Medical’s Drug Eluting Zilver® PTX™ Stent in New Zealand
Cook Medical’s Zilver Stent Receives Approval for Vascular Use In Canada
Boston Scientific to Market TAXUS® EXPRESS2 Stent System in Japan
CE Mark Granted for the Use of Drug-eluting Stent, TAXUS® Liberte™ in Diabetic Patients
Boston Scientific’s TAXUS® Liberte™ Long Stent Receives CE Mark Approval
Boston Scientific Launches Its Own Version of XIENCE™V Drug-Eluting Coronary Stent in Europe
8.CLINICAL TRIALS AND KEY STUDIES
Canadian Study Indicates Superior Clinical Benefits of Drug-Coated Stent
SPIRIT III Trial Confirms Superiority of Everolimus Eluting Coronary Stent, XIENCE™ V Over TAXUS® Stent
Network Meta-Analysis Demonstrates Low Mortality Rates for Both Drug-Eluting And Bare-Metal Stents
Study Proves Superiority of Cypher® Sirolimus-Eluting Coronary Stent in Reduction of Blood Clot Risks and Reintervention Compared to Taxus Stent
9.MAJOR PLAYERS
Angiotech Pharmaceuticals (Canada)
Boston Scientific Corp. (USA)
Cordis Corporation (JNJ) - (USA)
Cook Group, Inc. (USA)
Medtronic, Inc. (USA)
Medtronic Cardiovascular, Inc. (USA)
MIVI Technologies Inc. (Canada)
OrbusNeich (USA)
Sorin Biomedica Cardio (Italy)
Sun Biomedical Ltd. (USA)
10.MARKET ANALYTICS
11.THE UNITED STATES
Coronary Artery Disease - A US Perspective
Rapid Adoption of DES Technology in the US Market
Baby Boomers Boost Coronary Stent Market
Key Drivers of the US DES Market
Improved Treatment and Diagnosis
Long-Term Cost Reduction
Well-Organized Reimbursement System
Growing Patient Awareness
DES Technology – Economic Implications on the US Health Care System
Soaring Costs of Multivessel Treatment - Still a Major Problem
Competitive Scenario
Leading Players
Coronary Stents – Boston Scientific and JNJ Battle for Dominance
Regulatory Environment
12.JAPAN
Prospects Weighed down by Regulatory Entanglements
Japanese Government Steps in to Alleviate Pricing
Japanese Coronary Stents Command Higher Prices
Competitive Landscape
13.EUROPE
a.France
b.Germany
c.Italy
d.The United Kingdom
e.Spain
f.Russia
g.Rest of Europe
14.ASIA-PACIFIC
Coronary Stent Market in a Bubble Zone Now
Regional Players and their DES Development Efforts
Cost Focus Helps Stent Makers Win the Market Stunt
15.REST OF WORLD
Market Leaders
South Africa – Leading Players
Exhibits
Table 1: Growth in Angioplasty Procedures Vs Stent Penetration Worldwide: (2006)
Table 2: Percentage Breakdown of Leading Coronary Stents Manufacturer Revenues in the World –
Table 3: Percentage Breakdown of Leading Bare Metal Stents Manufacturer Revenues in the World –
Table 4: Percentage Breakdown of Leading Drug-Eluting Stent Manufacturer Revenues in the World –
Table 5: Global Coronary Stents Market by Region for the Period 2007-2015 (Sales in US$ Million)
Table 6: Percentage Breakdown (Dollar Sales) of Global Coronary Stents Market by Region for the Years 2008 & 2009
Table 7: Global Coronary Stents Market by Region for the Period 2007-2015 (Sales in Thousand Units)
Table 8: Percentage Breakdown (Unit Sales) of Global Coronary Stents Market by Region for the Years 2008 & 2009
Table 9: Global Bare Metal Stents Market by Region for the Period 2007-2015 (Sales in US$ Million)
Table 10: Percentage Breakdown (Dollar Sales) of Global Bare Metal Stents Market by Region for the Years 2008 & 2009
Table 11: Global Bare Metal Stents Market by Region for the Period 2007-2015 (Sales in Thousand Units)
Table 12: Percentage Breakdown (Unit Sales) of Global Bare Metal Stents Market by Region for the Years 2008 & 2009
Table 13: Global Drug Eluting Stents Market by Region for the Period 2007-2015 (Sales in US$ Million)
Table 14: Percentage Breakdown (Dollar Sales) of Global Drug Eluting Stents Market by Region for the Years 2008 & 2009
Table 15: Global Drug Eluting Stents Market by Region for the Period 2007-2015 (Sales in Thousand Units)
Table 16: Percentage Breakdown (Unit Sales) of Global Drug Eluting Stents Market by Region for the Years 2008 & 2009
Table 17: Percentage Breakdown of Leading Coronary Stents Manufacturer Revenues in the US –
Table 18: Percentage Breakdown of Leading Bare Metal Stents Manufacturer Revenues in the US –
Table 19: Percentage Breakdown of Leading Drug-Eluting Stents Manufacturer Revenues in the US –
Table 20: Coronary Stents Market by Segment in the US: 2007-2015 (Sales in US$ Million)
Table 21: Percentage Breakdown (Dollar Sales) of Coronary Stents Market by Segment in the US for the Years 2008 & 2009
Table 22: Coronary Stents Market by Segment in the US: 2007-2015 (Sales in Thousand Units)
Table 23: Percentage Breakdown (Unit Sales) of Coronary Stents Market by Segment in the US for the Years 2008 & 2009
Table 24: Comparative Analysis of Coronary Stent Prices –
Table 25: Percentage Breakdown of Leading Coronary Stent Manufacturer Value Sales in Japan –
Table 26: Percentage Breakdown of Leading Bare Metal Stent Manufacturer Value Sales in Japan –
Table 27: Percentage Breakdown of Leading Drug-Eluting Stent Manufacturer Value Sales in Japan –
Table 28: Coronary Stents Market by Segment in Japan: 2007-2015 (Sales in US$ Million)
Table 29: Percentage Breakdown (Dollar Sales) of Coronary Stents Market by Segment in Japan for the Years 2008 & 2009
Table 30: Coronary Stents Market by Segment in Japan: 2007-2015 (Sales in Thousand Units)
Table 31: Percentage Breakdown (Unit Sales) of Coronary Stents Market by Segment in Japan for the Years 2008 & 2009
Table 32: Percentage Breakdown of Leading Bare Metal Stent Manufacturer Value Sales in Europe –
Table 33: Percentage Breakdown of Leading Drug-Eluting Stent Manufacturer Value Sales in Europe –
Table 34: Coronary Stents Market by Region in Europe: 2007-2015 (Sales in US$ Million)
Table 35: Percentage Breakdown (Dollar Sales) of Coronary Stents Market by Region in Europe for the Years 2008 & 2009
Table 36: Coronary Stents Market by Region in Europe: 2007-2015 (Sales in Thousand Units)
Table 37: Percentage Breakdown (Unit Sales) of Coronary Stents Market by Region in Europe for the Years 2008 & 2009
Table 38: Coronary Stents Market by Segment in Europe: 2007-2015 (Sales in US$ Million)
Table 39: Percentage Breakdown (Dollar Sales) of Coronary Stents Market by Segment in Europe for the Years 2008 & 2009
Table 40: Coronary Stents Market by Segment in Europe: 2007-2015 (Sales in Thousand Units)
Table 41: Percentage Breakdown (Unit Sales) of Coronary Stents Market by Segment in Europe for the Years 2008 & 2009
Table 42: Coronary Stents Market by Segment in France: 2007-2015 (Sales in US$ Million)
Table 43: Percentage Breakdown (Dollar Sales) of Coronary Stents Market by Segment in France for the Years 2008 & 2009
Table 44: Coronary Stents Market by Segment in France: 2007-2015 (Sales in Thousand Units)
Table 45: Percentage Breakdown (Unit Sales) of Coronary Stents Market by Segment in France for the Years 2008 & 2009
Table 46: Coronary Stents Market by Segment in Germany: 2007-2015 (Sales in US$ Million)
Table 47: Percentage Breakdown (Dollar Sales) of Coronary Stents Market by Segment in Germany for the Years 2008 & 2009
Table 48: Coronary Stents Market by Segment in Germany: 2007-2015 (Sales in Thousand Units)
Table 49: Percentage Breakdown (Unit Sales) of Coronary Stents Market by Segment in Germany for the Years 2008 & 2009
Table 50: Coronary Stents Market by Segment in Italy: 2007-2015 (Sales in US$ Million)
Table 51: Percentage Breakdown (Dollar Sales) of Coronary Stents Market by Segment in Italy for the Years 2008 & 2009
Table 52: Coronary Stents Market by Segment in Italy: 2007-2015 (Sales in Thousand Units)
Table 53: Percentage Breakdown (Unit Sales) of Coronary Stents Market by Segment in Italy for the Years 2008 & 2009
Table 54: Coronary Stents Market by Segment in the UK: 2007-2015 (Sales in US$ Million)
Table 55: Percentage Breakdown (Dollar Sales) of Coronary Stents Market by Segment in the UK for the Years 2008 & 2009
Table 56: Coronary Stents Market by Segment in the UK: 2007-2015 (Sales in Thousand Units)
Table 57: Percentage Breakdown (Unit Sales) of Coronary Stents Market by Segment in the UK for the Years 2008 & 2009
Table 58: Coronary Stents Market by Segment in Spain: 2007-2015 (Sales in US$ Million)
Table 59: Percentage Breakdown (Dollar Sales) of Coronary Stents Market by Segment in Spain for the Years 2008 & 2009
Table 60: Coronary Stents Market by Segment in Spain: 2007-2015 (Sales in Thousand Units)
Table 61: Percentage Breakdown (Unit Sales) of Coronary Stents Market by Segment in Spain for the Years 2008 & 2009
Table 62: Coronary Stents Market by Segment in Russia: 2007-2015 (Sales in US$ Million)
Table 63: Percentage Breakdown (Dollar Sales) of Coronary Stents Market by Segment in Russia for the Years 2008 & 2009
Table 64: Coronary Stents Market by Segment in Russia: 2007-2015 (Sales in Thousand Units)
Table 65: Percentage Breakdown (Unit Sales) of Coronary Stents Market by Segment in Russia for the Years 2008 & 2009
Table 66: Coronary Stents Market by Segment in the Rest of Europe: 2007-2015 (Sales in US$ Million)
Table 67: Percentage Breakdown (Dollar Sales) of Coronary Stents Market by Segment in the Rest of Europe for the Years 2008 & 2009
Table 68: Coronary Stents Market by Segment in the Rest of Europe: 2007- 2015 (Sales in Thousand Units)
Table 69: Percentage Breakdown (Unit Sales) of Coronary Stents Market by Segment in the Rest of Europe for the Years 2008 & 2009
Table 70: Coronary Stents Market by Segment in Asia-Pacific: 2007-2015 (Sales in US$ Million)
Table 71: Percentage Breakdown (Dollar Sales) of Coronary Stents Market by Segment in Asia-Pacific for the Years 2008 & 2009
Table 72: Coronary Stents Market by Segment in Asia-Pacific: 2007-2015 (Sales in Thousand Units)
Table 73: Percentage Breakdown (Unit Sales) of Coronary Stents Market by Segment in Asia-Pacific for the Years 2008 & 2009
Table 74: Percentage Breakdown of Leading Coronary Stent Manufacturer Value Sales in Rest of World –
Table 75: Percentage Breakdown of Leading Coronary Stent Manufacturer Unit Sales in Rest of World –
Table 76: Coronary Stents Market by Segment in Rest of World: 2007-2015 (Sales in US$ Million)
Table 77: Percentage Breakdown (Dollar Sales) of Coronary Stents Market by Segment in Rest of World for the Years 2008 & 2009
Table 78: Coronary Stents Market by Segment in Rest of World: 2007-2015 (Sales in Thousand Units)
Table 79: Percentage Breakdown (Unit Sales) of Coronary Stents Market by Segment in Rest of World for the Years 2008 & 2009
Companies Profiled